As of Apr 2, 2025, the Brainsway stock's price-to-earnings ratio is 59.31. This results from the current EPS of $0.16 and stock price of $9.49.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | N/A | N/A | $6.48 | -$0.26 |
2022 | N/A | N/A | $2.47 | -$0.8 |
2021 | N/A | N/A | $7.7 | -$0.42 |
2020 | N/A | N/A | $7.54 | -$0.48 |
2019 | N/A | N/A | $9.75 | -$1 |
2018 | N/A | N/A | N/A | -$0.78 |
2017 | N/A | N/A | N/A | -$0.96 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 58.94 | -48.97% | $9.43 | $0.16 |
Sep 2024 | 115.5 | -61.94% | $9.24 | $0.08 |
Jun 2024 | 303.5 | N/A | $6.07 | $0.02 |
Mar 2024 | N/A | N/A | $5.29 | -$0.12 |
Dec 2023 | N/A | N/A | $6.48 | -$0.26 |
Sep 2023 | N/A | N/A | $4.04 | -$0.48 |
Jun 2023 | N/A | N/A | $2.28 | -$0.76 |
Mar 2023 | N/A | N/A | $1.76 | -$0.8 |
Dec 2022 | N/A | N/A | $2.47 | -$0.8 |
Sep 2022 | N/A | N/A | $3.61 | -$0.62 |
Jun 2022 | N/A | N/A | $4.83 | -$0.42 |
Mar 2022 | N/A | N/A | $8.73 | -$0.4 |
Dec 2021 | N/A | N/A | $7.7 | -$0.42 |
Sep 2021 | N/A | N/A | $8.06 | -$0.36 |
Jun 2021 | N/A | N/A | $10.2 | -$0.34 |
Stock name | PE ratio | Market cap |
---|---|---|
BWAY Brainsway Ltd | 55.94 | $148.76M |
OBIO Orchestra BioMed Holdings Inc | N/A | $124.3M |
BWAY's price to earnings ratio is 59.31 as of Apr 2, 2025.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Apr 2, 2025), Brainsway's stock price is $9.49. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.16. Therefore, Brainsway's PE ratio for today is 59.31. PE RATIO(59.31) = STOCK PRICE($9.49) / TTM EPS($0.16)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.